Smoking cessation and nicotine de-addiction market size to grow by USD 24,529.75 million between 2022 and 2027; Growth driven by rising adoption of online retailing – Technavio

The smoking cessation and nicotine de-addiction market size is forecasted to increase by USD 24,529.75 million from 2022 to 2027, at a CAGR of 12.59%, according to the recent market study by Technavio. The growth of the market will be driven by the rising adoption of online retailing, the increasing number of people trying to quit smoking, and growing health awareness among consumers. Charts & data tables about market and segment sizes for a historic period (2017-2021) and forecast period (2023-2027) have been covered in this report. Download a Sample Report

Technavio has announced its latest market research report titled Global Smoking Cessation and Nicotine De-addiction Market
Technavio has announced its latest market research report titled Global Smoking Cessation and Nicotine De-addiction Market

Vendor Analysis

The global smoking cessation and nicotine de-addiction market is fragmented due to the presence of numerous regional and international vendors that compete on price points and product quality. Key vendors are increasing their R&D investments to develop new products and improve their existing products. They have significant geographical coverage and strong relationships with end-users. These vendors are focusing on expanding their businesses internationally and are generating a significant volume of their net sales from their international operations. Hence, small and medium-sized vendors are struggling to capture market share from the leading vendors. Some of the key vendors covered in the report include:

  • Alchem International Pvt. Ltd. – The company offers smoking cessation and nicotine de-addiction products such as Nicotine patches, Nicotine gums, and Nicotine lozenges.
  • Alkalon AS – The company offers smoking cessation and nicotine de-addiction products such as Nicotine Chewing Gum.
  • Alvogen – The company offers smoking cessation and nicotine de-addiction products such as Levothyroxine Sodium Tablets.
  • British American Tobacco Plc – The company offers smoking cessation and nicotine de-addiction products under its Velo brand.
  • Axcentria Pharmaceuticals
  • Cambrex Corp.
  • CHEMNOVATIC Sp. z o.o. Sp. k
  • Cipla Ltd.
  • Dr. Reddys Laboratories Ltd.
  • Enorama Pharma AB
  • Imperial Brands Plc
  • Japan Tobacco Inc.
  • Johnson & Johnson
  • Lil Drug Store Products Inc.

Why Buy?

  • Add credibility to strategy
  • Analyzes competitor’s offerings
  • Get a holistic view of the market

Grow your profit margin with Technavio – Buy the Report

Key Benefits for Industry Players & Stakeholders – 

  • The report offers information on the criticality of vendor inputs, including R&D, CAPEX, and technology.
  • It also provides detailed analyses of the market’s competitive landscape and vendors’ product offerings.
  • The report also provides a qualitative and quantitative analysis of vendors to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Get a holistic overview of the smoking cessation and nicotine de-addiction market by industry experts to evaluate and develop growth strategies. Download Sample Report

Market Segmentation:

The market is segmented by distribution channel (drug stores and retailers, hospital pharmacies, and online retail), product (e-cigarette, NRT, and drug therapy), and geography (North America, Europe, Asia, and Rest of World (ROW)).

  • By distribution channel, the market growth will be significant in the drug stores and retailers segment during the forecast period. Vendors are expanding their businesses into local and regional markets. Most of their products are sold through specialty stores and other retail formats. Thus, the market is expected to witness maximum growth in the segment during the forecast period.
  • By product, the market will witness increased demand for e-cigarettes during the forecast period. Factors such as the launch of new products and continuous innovation by vendors are driving the growth of the segment.
  • North America will account for 32% of the market growth during the forecast period. Many people in the region are trying to quit smoking due to rising awareness and an increasing number of deaths caused by smoking. In addition, the presence of stringent regulations and the increasing use of e-cigarettes are expected to drive the growth of the regional market.

Market Dynamics:

Key Drivers:

  • Rising adoption of online retailing
  • Increasing number of people trying to quit smoking
  • Growing health awareness among consumers

The rise in the number of internet users has fostered the growth of the e-commerce industry worldwide. The increased customer inclination toward online shopping has led e-commerce companies to incorporate advanced security features to ensure efficient customer service and payments. E-commerce players are also focusing on developing customer-friendly websites to offer better product visibility. The growth of the e-commerce industry has encouraged market vendors to tap the growth potential by increasing their focus on the online customer segment. They are increasing the availability of their products through online distribution channels to drive more sales. All these factors are driving the growth of the market.

Major Trends:

  • New marketing initiatives
  • Rising number of organized retailing outlets distributing nicotine patches
  • Increasing availability through various distribution channels

Market players are coming up with various marketing strategies to increase revenue flow. They are introducing marketing campaigns to create awareness about quitting smoking. For instance, in January 2019, JUUL launched its first TV ad campaign targeting adults aged between 37 and 54 years. The campaign featured testimonials from people who used the company’s products to quit smoking. Such marketing campaigns are helping vendors increase their sales and expand their market shares. This trend is positively influencing the growth of the market.

Key Challenges:

  • Health issues associated with smoking cessation products
  • Increasing use of e-cigarettes among teenagers
  • Stringent regulations

The long terms use of smoking cessation products, such as nicotine gums, nicotine patches, lozenges, and e-cigarettes can cause various health problems. For instance, people using nicotine gums are at higher risk of hair loss, skin irritation, elevated blood pressure, irregular heartbeat, insulin resistance, gastrointestinal issues, and nausea. Nicotine gums also cause problems with teeth and jaw because of continuous chewing. Similarly, e-cigarettes contain acrolein, which can cause issues such as acute lung injury and chronic obstructive pulmonary disease (COPD). Many such health issues are hindering the growth of the market.

Gain instant access to 17,000+ market research reports. 
Technavio’s SUBSCRIPTION platform

What are the key data covered in this smoking cessation and nicotine de-addiction market report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the smoking cessation and nicotine de-addiction market between 2023 and 2027
  • Precise estimation of the size of the smoking cessation and nicotine de-addiction market and its contribution to the market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the smoking cessation and nicotine de-addiction market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of smoking cessation and nicotine de-addiction market vendors

Related Reports:

  • The addiction therapeutics market size is estimated to grow at a CAGR of 7.65% between 2022 and 2027. The addiction therapeutics market size is forecasted to increase by USD 9.86 billion. The market is segmented by distribution channel (hospital pharmacy, retail pharmacy, and others), type (alcohol addiction therapeutics, tobacco addiction therapeutics, and drug addiction therapeutics), and geography (North America, Europe, Asia, and the Rest of World (ROW)).
  • The nicotine patch market is expected to develop at the market’s growth momentum (CAGR) of 7.55% between 2021 and 2026 and the market size is expected to increase by USD 363.81 million. The market is segmented by product (24-hour and 16-hour nicotine patches) and geography (North America, Europe, APAC, South America, the Middle East, and Africa).
Smoking Cessation and Nicotine De-addiction Market Scope
Report CoverageDetails
Base year2022
Historic period2017-2021
Forecast period2023-2027
Growth momentum & CAGRAccelerate at a CAGR of 12.59%
Market growth 2023-2027USD 24,529.75 million
Market structureFragmented
YoY growth 2022-2023 (%)12.4
Regional analysisNorth America, Europe, Asia, and Rest of World (ROW)
Performing market contributionNorth America at 32%
Key countriesUS, Canada, Germany, UK, China, and India
Competitive landscapeLeading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiledAlchem International Pvt. Ltd., Alkalon AS, Alvogen, Axcentria Pharmaceuticals, British American Tobacco Plc, Cambrex Corp., CHEMNOVATIC Sp. z o.o. Sp. k, Cipla Ltd., Dr Reddys Laboratories Ltd., Enorama Pharma AB, Imperial Brands Plc, Japan Tobacco Inc., Johnson and Johnson, Lil Drug Store Products Inc., Perrigo Co. Plc, Pfizer Inc., Philip Morris International, Qnovia, Tvape, and Walgreen Co.
Market dynamicsParent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.
Customization purviewIf our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse through Technavio’s Health Care Market Reports

Table of contents:

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
    • Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
    • Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
    • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
    • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global smoking cessation and nicotine de-addiction market 2017 – 2021
    • Exhibit 18: Historic Market Size – Data Table on Global smoking cessation and nicotine de-addiction market 2017 – 2021 ($ million)
  • 4.2 Distribution channel Segment Analysis 2017 – 2021
    • Exhibit 19: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
  • 4.3 Product Segment Analysis 2017 – 2021
    • Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 – 2021
    • Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 – 2021
    • Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
    • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
    • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
    • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
    • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
    • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
  • 5.7 Market condition
    • Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel

  • 6.1 Market segments
    • Exhibit 30: Chart on Distribution Channel – Market share 2022-2027 (%)
    • Exhibit 31: Data Table on Distribution Channel – Market share 2022-2027 (%)
  • 6.2 Comparison by Distribution Channel
    • Exhibit 32: Chart on Comparison by Distribution Channel
    • Exhibit 33: Data Table on Comparison by Distribution Channel
  • 6.3 Drug stores and retailers – Market size and forecast 2022-2027
    • Exhibit 34: Chart on Drug stores and retailers – Market size and forecast 2022-2027 ($ million)
    • Exhibit 35: Data Table on Drug stores and retailers – Market size and forecast 2022-2027 ($ million)
    • Exhibit 36: Chart on Drug stores and retailers – Year-over-year growth 2022-2027 (%)
    • Exhibit 37: Data Table on Drug stores and retailers – Year-over-year growth 2022-2027 (%)
  • 6.4 Hospital pharmacies – Market size and forecast 2022-2027
    • Exhibit 38: Chart on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
    • Exhibit 39: Data Table on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
    • Exhibit 40: Chart on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
    • Exhibit 41: Data Table on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
  • 6.5 Online retail – Market size and forecast 2022-2027
    • Exhibit 42: Chart on Online retail – Market size and forecast 2022-2027 ($ million)
    • Exhibit 43: Data Table on Online retail – Market size and forecast 2022-2027 ($ million)
    • Exhibit 44: Chart on Online retail – Year-over-year growth 2022-2027 (%)
    • Exhibit 45: Data Table on Online retail – Year-over-year growth 2022-2027 (%)
  • 6.6 Market opportunity by Distribution Channel
    • Exhibit 46: Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Product

  • 7.1 Market segments
    • Exhibit 47: Chart on Product – Market share 2022-2027 (%)
    • Exhibit 48: Data Table on Product – Market share 2022-2027 (%)
  • 7.2 Comparison by Product
    • Exhibit 49: Chart on Comparison by Product
    • Exhibit 50: Data Table on Comparison by Product
  • 7.3 E-cigarette – Market size and forecast 2022-2027
    • Exhibit 51: Chart on E-cigarette – Market size and forecast 2022-2027 ($ million)
    • Exhibit 52: Data Table on E-cigarette – Market size and forecast 2022-2027 ($ million)
    • Exhibit 53: Chart on E-cigarette – Year-over-year growth 2022-2027 (%)
    • Exhibit 54: Data Table on E-cigarette – Year-over-year growth 2022-2027 (%)
  • 7.4 NRT – Market size and forecast 2022-2027
    • Exhibit 55: Chart on NRT – Market size and forecast 2022-2027 ($ million)
    • Exhibit 56: Data Table on NRT – Market size and forecast 2022-2027 ($ million)
    • Exhibit 57: Chart on NRT – Year-over-year growth 2022-2027 (%)
    • Exhibit 58: Data Table on NRT – Year-over-year growth 2022-2027 (%)
  • 7.5 Drug therapy – Market size and forecast 2022-2027
    • Exhibit 59: Chart on Drug therapy – Market size and forecast 2022-2027 ($ million)
    • Exhibit 60: Data Table on Drug therapy – Market size and forecast 2022-2027 ($ million)
    • Exhibit 61: Chart on Drug therapy – Year-over-year growth 2022-2027 (%)
    • Exhibit 62: Data Table on Drug therapy – Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by Product
    • Exhibit 63: Market opportunity by Product ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Exhibit 65: Chart on Market share by geography 2022-2027 (%)
    • Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison
    • Exhibit 67: Chart on Geographic comparison
    • Exhibit 68: Data Table on Geographic comparison
  • 9.3 North America – Market size and forecast 2022-2027
    • Exhibit 69: Chart on North America – Market size and forecast 2022-2027 ($ million)
    • Exhibit 70: Data Table on North America – Market size and forecast 2022-2027 ($ million)
    • Exhibit 71: Chart on North America – Year-over-year growth 2022-2027 (%)
    • Exhibit 72: Data Table on North America – Year-over-year growth 2022-2027 (%)
  • 9.4 Europe – Market size and forecast 2022-2027
    • Exhibit 73: Chart on Europe – Market size and forecast 2022-2027 ($ million)
    • Exhibit 74: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
    • Exhibit 75: Chart on Europe – Year-over-year growth 2022-2027 (%)
    • Exhibit 76: Data Table on Europe – Year-over-year growth 2022-2027 (%)
  • 9.5 Asia – Market size and forecast 2022-2027
    • Exhibit 77: Chart on Asia – Market size and forecast 2022-2027 ($ million)
    • Exhibit 78: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
    • Exhibit 79: Chart on Asia – Year-over-year growth 2022-2027 (%)
    • Exhibit 80: Data Table on Asia – Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
    • Exhibit 81: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
    • Exhibit 82: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
    • Exhibit 83: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
    • Exhibit 84: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
  • 9.7 US – Market size and forecast 2022-2027
    • Exhibit 85: Chart on US – Market size and forecast 2022-2027 ($ million)
    • Exhibit 86: Data Table on US – Market size and forecast 2022-2027 ($ million)
    • Exhibit 87: Chart on US – Year-over-year growth 2022-2027 (%)
    • Exhibit 88: Data Table on US – Year-over-year growth 2022-2027 (%)
  • 9.8 Germany – Market size and forecast 2022-2027
    • Exhibit 89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
    • Exhibit 90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
    • Exhibit 91: Chart on Germany – Year-over-year growth 2022-2027 (%)
    • Exhibit 92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
  • 9.9 China – Market size and forecast 2022-2027
    • Exhibit 93: Chart on China – Market size and forecast 2022-2027 ($ million)
    • Exhibit 94: Data Table on China – Market size and forecast 2022-2027 ($ million)
    • Exhibit 95: Chart on China – Year-over-year growth 2022-2027 (%)
    • Exhibit 96: Data Table on China – Year-over-year growth 2022-2027 (%)
  • 9.10 Canada – Market size and forecast 2022-2027
    • Exhibit 97: Chart on Canada – Market size and forecast 2022-2027 ($ million)
    • Exhibit 98: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
    • Exhibit 99: Chart on Canada – Year-over-year growth 2022-2027 (%)
    • Exhibit 100: Data Table on Canada – Year-over-year growth 2022-2027 (%)
  • 9.11 India – Market size and forecast 2022-2027
    • Exhibit 101: Chart on India – Market size and forecast 2022-2027 ($ million)
    • Exhibit 102: Data Table on India – Market size and forecast 2022-2027 ($ million)
    • Exhibit 103: Chart on India – Year-over-year growth 2022-2027 (%)
    • Exhibit 104: Data Table on India – Year-over-year growth 2022-2027 (%)
  • 9.12 UK – Market size and forecast 2022-2027
    • Exhibit 105: Chart on UK – Market size and forecast 2022-2027 ($ million)
    • Exhibit 106: Data Table on UK – Market size and forecast 2022-2027 ($ million)
    • Exhibit 107: Chart on UK – Year-over-year growth 2022-2027 (%)
    • Exhibit 108: Data Table on UK – Year-over-year growth 2022-2027 (%)
  • 9.13 Market opportunity by geography
    • Exhibit 109: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Exhibit 110: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
    • Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
    • Exhibit 112: Overview on factors of disruption
  • 11.4 Industry risks
    • Exhibit 113: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
    • Exhibit 114: Vendors covered
  • 12.2 Market positioning of vendors
    • Exhibit 115: Matrix on vendor position and classification
  • 12.3 Alchem International Pvt. Ltd.
    • Exhibit 116: Alchem International Pvt. Ltd. – Overview
    • Exhibit 117: Alchem International Pvt. Ltd. – Product / Service
    • Exhibit 118: Alchem International Pvt. Ltd. – Key offerings
  • 12.4 Alkalon AS
    • Exhibit 119: Alkalon AS – Overview
    • Exhibit 120: Alkalon AS – Product / Service
    • Exhibit 121: Alkalon AS – Key offerings
  • 12.5 Alvogen
    • Exhibit 122: Alvogen – Overview
    • Exhibit 123: Alvogen – Product / Service
    • Exhibit 124: Alvogen – Key offerings
  • 12.6 British American Tobacco Plc
    • Exhibit 125: British American Tobacco Plc – Overview
    • Exhibit 126: British American Tobacco Plc – Business segments
    • Exhibit 127: British American Tobacco Plc – Key news
    • Exhibit 128: British American Tobacco Plc – Key offerings
    • Exhibit 129: British American Tobacco Plc – Segment focus
  • 12.7 Cambrex Corp.
    • Exhibit 130: Cambrex Corp. – Overview
    • Exhibit 131: Cambrex Corp. – Product / Service
    • Exhibit 132: Cambrex Corp. – Key news
    • Exhibit 133: Cambrex Corp. – Key offerings
  • 12.8 Cipla Ltd.
    • Exhibit 134: Cipla Ltd. – Overview
    • Exhibit 135: Cipla Ltd. – Business segments
    • Exhibit 136: Cipla Ltd. – Key news
    • Exhibit 137: Cipla Ltd. – Key offerings
    • Exhibit 138: Cipla Ltd. – Segment focus
  • 12.9 Dr Reddys Laboratories Ltd.
    • Exhibit 139: Dr Reddys Laboratories Ltd. – Overview
    • Exhibit 140: Dr Reddys Laboratories Ltd. – Business segments
    • Exhibit 141: Dr Reddys Laboratories Ltd. – Key offerings
    • Exhibit 142: Dr Reddys Laboratories Ltd. – Segment focus
  • 12.10 Enorama Pharma AB
    • Exhibit 143: Enorama Pharma AB – Overview
    • Exhibit 144: Enorama Pharma AB – Product / Service
    • Exhibit 145: Enorama Pharma AB – Key news
    • Exhibit 146: Enorama Pharma AB – Key offerings
  • 12.11 Imperial Brands Plc
    • Exhibit 147: Imperial Brands Plc – Overview
    • Exhibit 148: Imperial Brands Plc – Business segments
    • Exhibit 149: Imperial Brands Plc – Key news
    • Exhibit 150: Imperial Brands Plc – Key offerings
    • Exhibit 151: Imperial Brands Plc – Segment focus
  • 12.12 Japan Tobacco Inc.
    • Exhibit 152: Japan Tobacco Inc. – Overview
    • Exhibit 153: Japan Tobacco Inc. – Business segments
    • Exhibit 154: Japan Tobacco Inc. – Key news
    • Exhibit 155: Japan Tobacco Inc. – Key offerings
    • Exhibit 156: Japan Tobacco Inc. – Segment focus
  • 12.13 Johnson and Johnson
    • Exhibit 157: Johnson and Johnson – Overview
    • Exhibit 158: Johnson and Johnson – Business segments
    • Exhibit 159: Johnson and Johnson – Key news
    • Exhibit 160: Johnson and Johnson – Key offerings
    • Exhibit 161: Johnson and Johnson – Segment focus
  • 12.14 Perrigo Co. Plc
    • Exhibit 162: Perrigo Co. Plc – Overview
    • Exhibit 163: Perrigo Co. Plc – Business segments
    • Exhibit 164: Perrigo Co. Plc – Key news
    • Exhibit 165: Perrigo Co. Plc – Key offerings
    • Exhibit 166: Perrigo Co. Plc – Segment focus
  • 12.15 Pfizer Inc.
    • Exhibit 167: Pfizer Inc. – Overview
    • Exhibit 168: Pfizer Inc. – Product / Service
    • Exhibit 169: Pfizer Inc. – Key news
    • Exhibit 170: Pfizer Inc. – Key offerings
  • 12.16 Philip Morris International
    • Exhibit 171: Philip Morris International – Overview
    • Exhibit 172: Philip Morris International – Business segments
    • Exhibit 173: Philip Morris International – Key offerings
    • Exhibit 174: Philip Morris International – Segment focus
  • 12.17 Tvape
    • Exhibit 175: Tvape – Overview
    • Exhibit 176: Tvape – Product / Service
    • Exhibit 177: Tvape – Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Exhibit 178: Inclusions checklist
    • Exhibit 179: Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Exhibit 180: Currency conversion rates for US$
  • 13.4 Research methodology
    • Exhibit 181: Research methodology
    • Exhibit 182: Validation techniques employed for market sizing
    • Exhibit 183: Information sources
  • 13.5 List of abbreviations
    • Exhibit 184: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

Leave a Reply

Your email address will not be published. Required fields are marked *